| Basics |
ProPhase Labs, Inc.
ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research and development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.
|
| IPO Date: |
May 1, 1994 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$14.95M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 3.57%
|
| Avg Daily Range (30 D): |
$0.02 | 7.01%
|
| Avg Daily Range (90 D): |
$0.03 | 8.27%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.18M |
| Avg Daily Volume (30 D): |
1.23M |
| Avg Daily Volume (90 D): |
5.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
435 |
| Avg Trade Size (Sh.) (30 D): |
844 |
| Avg Trade Size (Sh.) (90 D): |
768 |
| Institutional Trades |
| Total Inst.Trades: |
17 |
| Avg Inst. Trade: |
$.97M |
| Avg Inst. Trade (30 D): |
$4.5M |
| Avg Inst. Trade (90 D): |
$4.5M |
| Avg Inst. Trade Volume: |
.34M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.36M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
127.12K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-2.16
|
$.11
|
$-1.59
|
|
Diluted EPS
|
$-2.16
|
$.11
|
$-1.59
|
|
Revenue
|
$ 4.57M
|
$ 1.43M
|
$ -2.48M
|
|
Gross Profit
|
$ .81M
|
$ .53M
|
$ .92M
|
|
Net Income / Loss
|
$ -43.13M
|
$ 3.97M
|
$ -34.36M
|
|
Operating Income / Loss
|
$ -33.99M
|
$ -3.66M
|
$ -14.57M
|
|
Cost of Revenue
|
$ 3.76M
|
$ .91M
|
$ -3.41M
|
|
Net Cash Flow
|
$ -1.09M
|
$ -.59M
|
$ .12M
|
|
PE Ratio
|
|
|
|
|
